|
1
|
Madnani N, Khan K, Chauhan P and Parmar G:
Polycystic ovarian syndrome. Indian J Dermatol Venereol Leprol.
79:310–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Azziz R, Carmina E, Dewailly D,
Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen
OE, Legro RS, Norman RJ, Taylor AE and Witchel SF: Positions
statement: Criteria for defining polycystic ovary syndrome as a
predominantly hyperandrogenic syndrome: An androgen excess society
guideline. J Clin Endocrinol Metab. 91:4237–4245. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trikudanathan S: Polycystic ovarian
syndrome. Med Clin North Am. 99:221–235. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Legro RS, Kunselman AR, Dodson WC and
Dunaif A: Prevalence and predictors of risk for type 2 diabetes
mellitus and impaired glucose tolerance in polycystic ovary
syndrome: A prospective, controlled study in 254 affected women. J
Clin Endocrinol Metab. 84:165–169. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lindholm A, Andersson L, Eliasson M, Bixo
M and Sundstrom-Poromaa I: Prevalence of symptoms associated with
polycystic ovary syndrome. Int J Gynaecol Obstet. 102:39–43. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fearnley EJ, Marquart L, Spurdle AB,
Weinstein P and Webb PM; Australian Ovarian Cancer Study Group and
Australian National Endometrial Cancer Study Group, : Polycystic
ovary syndrome increases the risk of endometrial cancer in women
aged less than 50 years: An Australian case-control study. Cancer
Causes Control. 21:2303–2308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Das M, Djahanbakhch O, Hacihanefioglu B,
Saridogan E, Ikram M, Ghali L, Raveendran M and Storey A: Granulosa
cell survival and proliferation are altered in polycystic ovary
syndrome. J Clin Endocrinol Metab. 93:881–887. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Erickson GF, Magoffin DA, Garzo VG, Cheung
AP and Chang RJ: Granulosa cells of polycystic ovaries: Are they
normal or abnormal? Hum Reprod. 7:293–299. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ying SY, Chang DC, Miller JD and Lin SL:
The microRNA: Overview of the RNA gene that modulates gene
functions. Methods Mol Biol. 342:1–18. 2006.PubMed/NCBI
|
|
10
|
Dehwah MA, Xu A and Huang Q: MicroRNAs and
type 2 diabetes/obesity. J Genet Genomics. 39:11–18. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sang Q, Yao Z, Wang H, Feng R, Wang H,
Zhao X, Xing Q, Jin L, He L, Wu L and Wang L: Identification of
microRNAs in human follicular fluid: Characterization of microRNAs
that govern steroidogenesis in vitro and are associated with
polycystic ovary syndrome in vivo. J Clin Endocrinol Metab.
98:3068–3079. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sørensen AE, Wissing ML, Salö S, Englund
AL and Dalgaard LT: MicroRNAs related to polycystic ovary syndrome
(PCOS). Genes (Basel). 5:684–708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang L, Huang J, Li L, Chen Y, Chen X,
Zhao X and Yang D: MicroRNA-93 promotes ovarian granulosa cells
proliferation through targeting CDKN1A in polycystic ovarian
syndrome. J Clin Endocrinol Metab. 100:E729–E738. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang L, Huang J, Chen Y, Yang Y, Li R, Li
Y, Chen X and Yang D: Identification of several circulating
microRNAs from a genome-wide circulating microRNA expression
profile as potential biomarkers for impaired glucose metabolism in
polycystic ovarian syndrome. Endocrine. 53:280–290. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sirotkin AV, Lauková M, Ovcharenko D,
Brenaut P and Mlyncek M: Identification of microRNAs controlling
human ovarian cell proliferation and apoptosis. J Cell Physiol.
223:49–56. 2010.PubMed/NCBI
|
|
16
|
McCallie B, Schoolcraft WB and Katz-Jaffe
MG: Aberration of blastocyst microRNA expression is associated with
human infertility. Fertil Steril. 93:2374–2382. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group, . Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome. Fertil Steril. 81:19–25. 2004. View Article : Google Scholar
|
|
18
|
Yoshiji H, Kuriyama S, Yoshii J, Yamazaki
M, Kikukawa M, Tsujinoue H, Nakatani T and Fukui H: Vascular
endothelial growth factor tightly regulates in vivo development of
murine hepatocellular carcinoma cells. Hepatology. 28:1489–1496.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sullivan JP, Spinola M, Dodge M, Raso MG,
Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, et
al: Aldehyde dehydrogenase activity selects for lung adenocarcinoma
stem cells dependent on notch signaling. Cancer Res. 70:9937–9948.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) methods. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv D, Ding S, Chen P, Bei Y, Zhong C and
Xiao J: Abstract 221: miR-19b protects myocardial ischemia
reperfusion injury. Cir Res. 117:A2212015.
|
|
22
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu X and Moscinski LC: Cdc2: A monopotent
or pluripotent CDK? Cell Prolif. 44:205–211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huat TJ, Khan AA, Pati S, Mustafa Z,
Abdullah JM and Jaafar H: IGF-1 enhances cell proliferation and
survival during early differentiation of mesenchymal stem cells to
neural progenitor-like cells. BMC Neurosci. 15:912014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yakar S, Rosen CJ, Beamer WG,
Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J,
Boisclair YR and LeRoith D: Circulating levels of IGF-1 directly
regulate bone growth and density. J Clin Invest. 110:771–781. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thierry van Dessel HJ, Lee PD, Faessen G,
Fauser BC and Giudice LC: Elevated serum levels of free
insulin-like growth factor I in polycystic ovary syndrome. J Clin
Endocrinol Metab. 84:3030–3035. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Amin AF, Abd el-Aal DE, Darwish AM and
Meki AR: Evaluation of the impact of laparoscopic ovarian drilling
on Doppler indices of ovarian stromal blood flow, serum vascular
endothelial growth factor and insulin-like growth factor-1 in women
with polycystic ovary syndrome. Fertil Steril. 79:938–941. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abd El Aal DE, Mohamed SA, Amine AF and
Meki AR: Vascular endothelial growth factor and insulin-like growth
factor-1 in polycystic ovary syndrome and their relation to ovarian
blood flow. Eur J Obstet Gynecol Reprod Biol. 118:219–224. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bergh C, Carlsson B, Olsson JH, Selleskog
U and Hillensjö T: Regulation of androgen production in cultured
human thecal cells by insulin-like growth factor I and insulin.
Fertil Steril. 59:323–331. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cara JF and Rosenfield RL: Insulin-like
growth factor I and insulin potentiate luteinizing hormone-induced
androgen synthesis by rat ovarian thecal-interstitial cells.
Endocrinology. 123:733–739. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cara JF: Insulin-like growth factors,
insulin-like growth factor binding proteins and ovarian androgen
production. Horm Res. 42:49–54. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Franks S: Polycystic ovary syndrome. N
Engl J Med. 333:853–861. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Utiger RD: Insulin and the polycystic
ovary syndrome. N Engl J Med. 335:657–658. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dunaif A: Insulin resistance and the
polycystic ovary syndrome: mechanism and implications for
pathogenesis. Endocr Rev. 18:774–800. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Willis D, Mason H, Gilling-Smith C and
Franks S: Modulation by insulin of follicle-stimulating hormone and
luteinizing hormone actions in human granulosa cells of normal and
polycystic ovaries. J Clin Endocrinol Metab. 81:302–309. 1996.
View Article : Google Scholar : PubMed/NCBI
|
